fallen considerably, and the company was rejecting some seemingly profitable projects because the hurdle rate was too high, so it lowered it to $9\mathrm{.}5\%.$ As far as he knew, that was the end of the story. brief discussion, they ask the person who raised the question in the first place to analyze the company's debt and equity and report back in a week with her estimate of the company's weighted average cost of capital. capital structure is shown in the popup window:

Assist the financial analyst by answering these questions.

Questions

Compute the yield to maturity and the after$-$tax cost of debt for the two bond issues.

Compute BioCom's cost of preferred stock.

Compute BioCom's cost of common equity. Use the average of results from the dividend growth model and the security market line

Compute BioCom's weighted average cost of capital. Should you use book values or market values for this computation?

Some of BioCom's projects are low risk, some average risk, and some high risk. Should BioCom use the same cost of capital to evaluate all its projects, or should it adjust the discount rate to reflect different levels of risk?

Data table

$\backslash$table$[[$Click on the Icon $$ in order to copy its content into a spreadsheet.$],[$Type of Capital,Percent of Book Value,Percent of Market Value$],[$Bond $1,20\%,17\%$

Each question should be answered separately. Questions $1-6$